Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer

In what was likely a compensatory response to rapid bone loss, CIOF patients' OPG levels increased at 6 months and then decreased at 12 months to values greater than baseline assessments. This phenomenon is described in other diseases, but never before in CIOF.